Literature DB >> 19235442

Unruptured cerebral aneurysms presenting with ischemic events.

Nancy McLaughlin1, Michel W Bojanowski.   

Abstract

BACKGROUND: Patients harboring an unruptured cerebral aneurysm may present with ischemic events. The goal of this study is to assess the clinical and radiological characteristics and the outcome following treatment of these patients.
METHODS: The study population included 463 patients with unruptured cerebral aneurysms treated between January 2000 and November 2006. Patients with aneurysms manifesting with ischemic events were included. Outcome was assessed 12 months following aneurysm treatment using the modified Rankin scale.
RESULTS: Eleven patients were included in this series. An acute ischemic lesion in the symptomatic territory was demonstrated in six patients. The aneurysms were located on the internal carotid artery (n=4), middle cerebral artery (n=4), superior cerebellar artery (n=2) and basilar artery (n=1). They measured 10 mm or less (n=7); 11-20 mm (n=2); more than 21 mm (n=2). Five aneurysms were partially thrombosed on imaging. Five patients were referred for coiling. Of these, one patient had an unsuccessful coiling attempt, one had a residual neck, and three presented an aneurysm recurrence. Six patients were treated surgically. Symptomatic thromboembolism occurred after surgery in three patients. Complete aneurysm exclusion was documented in five of six operated patients. Nine of the ten treated patients had a favorable outcome.
CONCLUSION: Even though aneurysms presenting with ischemic events are often small and located on the anterior circulation, in this series the risk of thromboembolic events following aneurysm treatment is noteworthy. This information is relevant given the possible benign natural history in terms of stroke and risk of bleeding for some of these aneurysms.

Entities:  

Mesh:

Year:  2008        PMID: 19235442     DOI: 10.1017/s0317167100009379

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  7 in total

1.  Treatment and outcome of thrombosed aneurysms of the middle cerebral artery: institutional experience and a systematic review.

Authors:  Alba Scerrati; Giovanni Sabatino; Giuseppe Maria Della Pepa; Alessio Albanese; Enrico Marchese; Alfredo Puca; Alessandro Olivi; Carmelo Lucio Sturiale
Journal:  Neurosurg Rev       Date:  2018-05-22       Impact factor: 3.042

2.  Cerebral ischemia complicating intracranial aneurysm: a warning sign of imminent rupture?

Authors:  B Guillon; B Daumas-Duport; O Delaroche; K Warin-Fresse; M Sévin; F Hérisson; E Auffray-Calvier; H Desal
Journal:  AJNR Am J Neuroradiol       Date:  2011-08-25       Impact factor: 3.825

3.  Embolic stroke secondary to spontaneous thrombosis of unruptured intracranial aneurysm: Report of three cases.

Authors:  Antonio Arauz; Hernán M Patiño-Rodríguez; Mónica Chavarría-Medina; Mayra Becerril; José G Merino; Marco Zenteno
Journal:  Interv Neuroradiol       Date:  2015-12-07       Impact factor: 1.610

4.  Lateral Medullary Ischemic Infarct Caused by Posterior Inferior Cerebellar Artery Aneurysm.

Authors:  Muhammad Taimur Malik; Edgar J Kenton Iii; Dana Vanino; Shamsher S Dalal; Ramin Zand
Journal:  Case Rep Neurol       Date:  2017-12-21

5.  Brain ischemia due to direct vascular compression associate with rapid enlargement of unruptured middle cerebral artery aneurysm: A case report.

Authors:  Hiroshi Miyachi; Kohei Suzuki; Shohei Nagasaka; Takehiro Kitagawa; Junkoh Yamamoto
Journal:  Surg Neurol Int       Date:  2021-03-24

6.  Endovascular management of symptomatic cerebral aneurysm thromboembolism due to pre-aneurysmal arterial stenosis.

Authors:  Torin Karsonovich; Ajeet Gordhan
Journal:  SAGE Open Med Case Rep       Date:  2017-09-04

7.  Prevalence, predictors and prognosis of incidental intracranial aneurysms in patients with suspected TIA and minor stroke: a population-based study and systematic review.

Authors:  Robert Hurford; Isabel Taveira; Wilhelm Kuker; Peter M Rothwell
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-11-04       Impact factor: 10.154

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.